Sensenig Bethany Insider Trades

Insider Trading History

Track insider trading activity for Sensenig Bethany. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Director
Holding Value $0 0 shares
Last Trade
Feb 19, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$230k 4,475 shares
$51.35
$44.70
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Director
Holding Value $200k 4,475 shares
Last Trade
Feb 19, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$230k 4,475 shares
$51.35
$44.70
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Director
Holding Value $146k 3,258 shares
Last Trade
Feb 19, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$228k 4,475 shares
$51.01
$44.70
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Director
Holding Value $222k 4,977 shares
Last Trade
Feb 18, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$400k 7,966 shares
$50.20
$44.70
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
Director
Holding Value $1.21M 45,000 shares
Last Trade
Oct 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$542k 45,000 shares
$12.05
$26.95
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Director
Holding Value $0 0 shares
Last Trade
Aug 14, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$227k 5,369 shares
$42.25
$44.70
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Director
Holding Value $240k 5,369 shares
Last Trade
Feb 22, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$177k 5,369 shares
$33.05
$44.70
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Director
Holding Value $0 0 shares
Last Trade
Feb 22, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$177k 5,369 shares
$33.05
$44.70
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Director
Holding Value $326k 7,296 shares
Last Trade
Feb 19, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$245k 7,296 shares
$33.52
$44.70
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Director
Holding Value $369k 8,252 shares
Last Trade
Feb 22, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$231k 8,252 shares
$27.94
$44.70
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Director
Holding Value $1.08M 24,153 shares
Last Trade
Aug 17, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$730k 24,153 shares
$30.22
$44.70
9 Meters Biopharma
9 Meters Biopharma NMTR
Chief Financial Officer
Holding Value $2.97k 41,077 shares
Last Trade
Apr 21, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$11k 9,100 shares
$1.21
$0.07
9 Meters Biopharma
9 Meters Biopharma NMTR
Chief Financial Officer
Holding Value $3.62k 50,177 shares
Last Trade
Mar 27, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$67.2k 50,177 shares
$1.34
$0.07
9 Meters Biopharma
9 Meters Biopharma NMTR
Chief Financial Officer
Holding Value $93.9k 1,300,000 shares
Last Trade
Jan 18, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$22M 1,300,000 shares
$16.90
$0.07

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up